Cargando…

The Future of Ischemic Stroke: Flow from Prehospital Neuroprotection to Definitive Reperfusion

Recent advances in ischemic stroke enable a seamless transition of the patient flow from the prehospital setting to definitive reperfusion, without the arbitrary separation of therapeutic phases of ischemia based on time alone. In 2013, the framework to understand and directly address the pathophysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ip, Hing Lung, Liebeskind, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062315/
https://www.ncbi.nlm.nih.gov/pubmed/25187786
http://dx.doi.org/10.1159/000357164
_version_ 1782321627284897792
author Ip, Hing Lung
Liebeskind, David S.
author_facet Ip, Hing Lung
Liebeskind, David S.
author_sort Ip, Hing Lung
collection PubMed
description Recent advances in ischemic stroke enable a seamless transition of the patient flow from the prehospital setting to definitive reperfusion, without the arbitrary separation of therapeutic phases of ischemia based on time alone. In 2013, the framework to understand and directly address the pathophysiology of cerebral blood flow that determines the timeline or evolution of ischemia in an individual case is given. This continuum of flow and the homeostasis of brain perfusion balanced by collaterals may be captured with serial imaging. Ongoing imaging core laboratory activities permit large-scale measurement of angiographic and tissue biomarkers of ischemia. Prehospital neuroprotection has become a reality and may be combined with revascularization therapies. Recent studies confirm that image-guided thrombolysis may be achieved without restrictive time windows. Baseline imaging patterns may be used to predict response to therapy and serial imaging may discern recanalization and reperfusion. Advanced techniques, such as arterial spin-labeled MRI, may also report hyperperfusion associated with hemorrhagic transformation. Endovascular therapies, including novel stent retriever devices, may augment revascularization and angiographic core laboratories may define optimal reperfusion. Serial evaluation of collaterals and reperfusion may identify definitive reperfusion linked with good clinical outcome rather than imposing arbitrary definitions of effective recanalization. Reperfusion injury and hemorrhagic transformation of various types may be detailed to explain clinical outcomes. Similar approaches may be used in intracranial atherosclerosis where flow, and not the degree of luminal stenosis, is paramount. Fractional flow may now be measured with computational fluid dynamics to identify high-risk lesions that require revascularization to restore the equilibrium of antegrade and collateral perfusion. Serial perfusion imaging of such cases may also illustrate inadequate cerebral blood volume gradients that may be more informative than blood flow delay alone. In sum, the growing understanding of collateral perfusion throughout all stages of ischemic stroke provides a framework for the future of ischemic stroke.
format Online
Article
Text
id pubmed-4062315
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-40623152014-09-03 The Future of Ischemic Stroke: Flow from Prehospital Neuroprotection to Definitive Reperfusion Ip, Hing Lung Liebeskind, David S. Interv Neurol Review Recent advances in ischemic stroke enable a seamless transition of the patient flow from the prehospital setting to definitive reperfusion, without the arbitrary separation of therapeutic phases of ischemia based on time alone. In 2013, the framework to understand and directly address the pathophysiology of cerebral blood flow that determines the timeline or evolution of ischemia in an individual case is given. This continuum of flow and the homeostasis of brain perfusion balanced by collaterals may be captured with serial imaging. Ongoing imaging core laboratory activities permit large-scale measurement of angiographic and tissue biomarkers of ischemia. Prehospital neuroprotection has become a reality and may be combined with revascularization therapies. Recent studies confirm that image-guided thrombolysis may be achieved without restrictive time windows. Baseline imaging patterns may be used to predict response to therapy and serial imaging may discern recanalization and reperfusion. Advanced techniques, such as arterial spin-labeled MRI, may also report hyperperfusion associated with hemorrhagic transformation. Endovascular therapies, including novel stent retriever devices, may augment revascularization and angiographic core laboratories may define optimal reperfusion. Serial evaluation of collaterals and reperfusion may identify definitive reperfusion linked with good clinical outcome rather than imposing arbitrary definitions of effective recanalization. Reperfusion injury and hemorrhagic transformation of various types may be detailed to explain clinical outcomes. Similar approaches may be used in intracranial atherosclerosis where flow, and not the degree of luminal stenosis, is paramount. Fractional flow may now be measured with computational fluid dynamics to identify high-risk lesions that require revascularization to restore the equilibrium of antegrade and collateral perfusion. Serial perfusion imaging of such cases may also illustrate inadequate cerebral blood volume gradients that may be more informative than blood flow delay alone. In sum, the growing understanding of collateral perfusion throughout all stages of ischemic stroke provides a framework for the future of ischemic stroke. S. Karger AG 2014-05 2014-03-21 /pmc/articles/PMC4062315/ /pubmed/25187786 http://dx.doi.org/10.1159/000357164 Text en Copyright © 2013 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Review
Ip, Hing Lung
Liebeskind, David S.
The Future of Ischemic Stroke: Flow from Prehospital Neuroprotection to Definitive Reperfusion
title The Future of Ischemic Stroke: Flow from Prehospital Neuroprotection to Definitive Reperfusion
title_full The Future of Ischemic Stroke: Flow from Prehospital Neuroprotection to Definitive Reperfusion
title_fullStr The Future of Ischemic Stroke: Flow from Prehospital Neuroprotection to Definitive Reperfusion
title_full_unstemmed The Future of Ischemic Stroke: Flow from Prehospital Neuroprotection to Definitive Reperfusion
title_short The Future of Ischemic Stroke: Flow from Prehospital Neuroprotection to Definitive Reperfusion
title_sort future of ischemic stroke: flow from prehospital neuroprotection to definitive reperfusion
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062315/
https://www.ncbi.nlm.nih.gov/pubmed/25187786
http://dx.doi.org/10.1159/000357164
work_keys_str_mv AT iphinglung thefutureofischemicstrokeflowfromprehospitalneuroprotectiontodefinitivereperfusion
AT liebeskinddavids thefutureofischemicstrokeflowfromprehospitalneuroprotectiontodefinitivereperfusion
AT iphinglung futureofischemicstrokeflowfromprehospitalneuroprotectiontodefinitivereperfusion
AT liebeskinddavids futureofischemicstrokeflowfromprehospitalneuroprotectiontodefinitivereperfusion